Preventive healthcare can quickly become overwhelming. Clinics offer annual blood panels, hormone testing, tumor markers, ultrasound packages, genetic tests, and full-body scans, all promising to find problems early and provide reassurance.

More testing does not always lead to better health. Every screening test can produce false-positive results, incidental findings, repeat imaging, biopsies, treatment, cost, and anxiety. Some abnormalities would never have caused symptoms or affected a person’s life.

Research on broad general health checks has found that they can increase the number of diagnoses without reducing overall, cardiovascular, or cancer mortality. Effective prevention usually relies on a smaller number of targeted screenings for which early detection has been shown to improve outcomes.

The goal is to identify important problems early enough to make a difference while keeping the burden of testing reasonable.

Before Using This Guide

The recommendations below describe a practical minimum for adults who do not have concerning symptoms, major chronic conditions, previous high-risk findings, or a known hereditary syndrome.

Symptoms require diagnostic evaluation regardless of age. Unexplained bleeding, persistent pain, a new lump, shortness of breath, neurological changes, unexplained weight loss, or a lasting change in bowel habits should not wait for the next scheduled screening.

Family history, smoking, pregnancy complications, medications, previous test results, and genetic risk may justify earlier or more frequent testing. Recommendations also differ between countries, so exact ages and intervals should be checked against local guidance.

What Makes a Screening Test Worth Doing?

A useful screening program looks for a condition that is common or serious, can remain silent before symptoms appear, can be detected with reasonable accuracy, and can be treated more effectively when found early.

A screening test should also have a clear follow-up pathway. Before agreeing to one, it is worth asking what condition the test is looking for, whether people with your risk profile benefit from it, what happens after an abnormal result, and whether follow-up may involve radiation, biopsies, or procedures.

Most screening does not need to happen every year. Some tests are repeated annually, many are performed every few years, and some are recommended only once.

For example, a healthy adult younger than 40 with consistently normal blood pressure and no major risk factors may only need blood-pressure screening every three to five years. From age 40, annual screening is generally suggested. A high reading in a clinic should usually be confirmed with home measurements or ambulatory monitoring before hypertension is diagnosed.

Screening in Your 20s: Establish the Foundation

For most healthy adults, prevention during the 20s is about establishing a baseline, identifying major risk factors, completing vaccinations, and making sure targeted screening is up to date. Extensive annual laboratory testing is rarely necessary.

Blood pressure should be measured periodically. Adults aged 18 to 39 with a previous normal reading and no increased risk may only need testing every three to five years, while people with elevated readings, excess weight, diabetes, kidney disease, or a strong family history may need more frequent checks.

A lipid profile in early adulthood can identify high cholesterol and possible inherited lipid disorders. Measuring lipoprotein(a), or Lp(a), at least once may also help identify genetically driven cardiovascular risk that is not visible in a standard cholesterol panel.

Most adults should confirm that they have been screened for HIV at least once. Hepatitis C screening is also recommended across a broad adult age range and is usually performed once when no continuing exposure risk is present.

Sexually transmitted infection testing should be based on sexual history, pregnancy, local prevalence, and individual risk. For people with a cervix, cervical cancer screening usually begins in early adulthood. Under current final USPSTF guidance, cervical cytology is performed every three years from ages 21 to 29, while several accepted testing strategies are available from ages 30 to 65.

Preventive care should also include a review of mood, anxiety, sleep, alcohol, nicotine, vaping, recreational drugs, stress, and medication use. Vaccination history should be checked against the current national adult schedule, since recommendations change over time and depend on age, pregnancy, medical conditions, travel, occupation, and immune status.

Minimum Screening Checklist for Your 20s

Blood pressure has been measured and the next check is planned.

Family history of early heart disease, stroke, diabetes, and cancer has been documented.

A baseline lipid profile has been completed or discussed.

A once-in-a-lifetime Lp(a) measurement has been discussed.

HIV screening has been completed.

Hepatitis C screening has been completed.

Cervical screening is up to date, if applicable.

STI testing has been discussed when relevant.

Vaccination history has been reviewed.

Mental health, alcohol, nicotine, sleep, and medications have been reviewed.

Screening in Your 30s: Reassess Changing Risks

The basic screening priorities from your 20s remain relevant, but the 30s are a useful time to reassess how your risk profile has changed. Weight gain, rising blood pressure, reduced activity, sleep problems, smoking, pregnancy history, and new family diagnoses can all affect the preventive plan.

Continue periodic blood-pressure checks and repeat lipid testing according to previous results and risk factors. A normal test from ten years ago no longer describes current risk, although normal results do not automatically need to be repeated every year.

The USPSTF recommends screening adults aged 35 to 70 who have overweight or obesity for prediabetes and type 2 diabetes. Earlier testing may be appropriate for people with additional risk factors, including a history of gestational diabetes, previous elevated glucose, polycystic ovary syndrome, certain medications, or a strong family history.

Common screening methods include HbA1c, fasting glucose, and an oral glucose-tolerance test. Finding prediabetes is most useful when it leads to practical support involving physical activity, nutrition, weight management, and follow-up.

Pregnancy complications can also provide important information about long-term health. Gestational diabetes, pregnancy-related hypertension, pre-eclampsia, and preterm birth may increase future cardiovascular or metabolic risk and should remain part of the medical record.

Minimum Screening Checklist for Your 30s

Blood-pressure screening is current.

Lipids and major cardiovascular risk factors have been reviewed.

Diabetes screening has been discussed from age 35 when overweight, obesity, or other risk factors are present.

Cervical screening is up to date, if applicable.

HIV, hepatitis C, and risk-based STI testing are complete.

Vaccinations are current.

Pregnancy complications are included in the long-term medical history, if applicable.

Family history has been updated.

Mental health, sleep, alcohol, nicotine, and medications have been reviewed.

Screening in Your 40s: Major Age-Based Screening Begins

Several high-value screening programs begin during the 40s. The preventive minimum becomes more structured, but a targeted plan remains more useful than an annual search for every possible abnormality.

Annual blood-pressure screening is generally suggested from age 40, or earlier for people at increased risk. Cardiovascular prevention decisions also begin to rely more heavily on overall risk rather than one laboratory result. Age, blood pressure, cholesterol, smoking, diabetes, kidney disease, family history, and other risk-enhancing factors can all affect the decision to use preventive medication.

Coronary artery calcium scanning can sometimes help refine risk when treatment decisions remain uncertain, but it is not a routine scan for every adult entering their 40s.

Diabetes screening remains important for adults aged 35 to 70 who have overweight or obesity. The interval between tests depends on the initial result and whether risk factors change.

For women at average risk, the USPSTF recommends mammography every two years from age 40 through age 74. People with a strong family history, known high-risk genetic variants, or previous high-risk breast findings may need earlier or additional screening.

Average-risk colorectal cancer screening should begin at age 45 and continue through age 75. Options include annual fecal immunochemical testing, stool DNA-FIT every one to three years, CT colonography every five years, or colonoscopy every ten years after a normal result. A positive stool-based test usually requires colonoscopy.

People with a cervix should generally continue cervical screening through age 65, provided previous screening has been adequate and no high-risk history is present.

Minimum Screening Checklist for Your 40s

Blood pressure is checked approximately every year.

Lipids and overall cardiovascular risk have been assessed.

Diabetes screening is current when recommended.

Mammography has begun from age 40, if applicable.

Colorectal cancer screening has begun from age 45.

Cervical screening remains current, if applicable.

Vaccination history has been reviewed.

Smoking, alcohol, mood, sleep, weight changes, medications, and family history have been reviewed.

Earlier or additional screening has been considered when individual risk is elevated.

Screening in Your 50s and Beyond: Focus on Higher-Impact Risks

From the 50s onward, the likelihood of many chronic diseases increases. Screening can offer greater benefits, but decisions also become more individualized because overall health, previous results, life expectancy, and the ability to benefit from treatment matter.

Continue regular blood-pressure checks, cardiovascular-risk assessment, diabetes screening when appropriate, and established cancer-screening programs.

Colorectal cancer screening generally continues through age 75. From ages 76 to 85, the decision becomes selective and depends on previous screening history, overall health, and whether treatment would be appropriate.

Biennial mammography generally continues through age 74 under USPSTF guidance. Cervical screening may usually stop after age 65 when previous screening has been adequate and no high-risk history is present.

Annual low-dose CT screening is recommended for adults aged 50 to 80 who have at least a 20 pack-year smoking history and currently smoke or stopped within the past 15 years. Routine chest X-rays and full-body CT scans are not substitutes for a structured lung-cancer screening program.

For men aged 55 to 69, PSA screening should be an individual decision made after discussing potential benefits and harms. PSA can help detect aggressive cancer, but it can also identify slow-growing cancers that would never have caused symptoms. The USPSTF recommends against routine PSA screening in men aged 70 and older.

Vaccination becomes increasingly important after age 50. Depending on current national guidance and individual risk, recommended vaccines may include those against shingles, pneumococcal disease, influenza, COVID-19, RSV, and other infections.

Minimum Screening Checklist for Your 50s

Blood pressure and cardiovascular risk assessment are current.

Lipid management has been reviewed.

Diabetes screening is current when recommended.

Colorectal cancer screening is current.

Mammography continues, if applicable.

Cervical screening continues until the appropriate stopping point, if applicable.

Lung cancer screening eligibility has been assessed when there is a significant smoking history.

PSA screening has been discussed between ages 55 and 69, if applicable.

Vaccinations have been reviewed against the current schedule.

Medications, smoking, alcohol, mood, sleep, physical activity, and family history have been reviewed.

Add These Screenings From Age 65

Women aged 65 and older should be screened for osteoporosis using bone-density testing. Postmenopausal women younger than 65 may also need screening when a clinical risk assessment shows elevated fracture risk. Evidence remains insufficient to recommend routine population screening for all men, so individual risk assessment remains important.

Men aged 65 to 75 who have ever smoked should receive a one-time abdominal ultrasound to screen for abdominal aortic aneurysm. Screening can be considered selectively for men in this age group who have never smoked.

Later-life prevention should also extend beyond laboratory tests and cancer screening. Falls risk, mobility, hearing, vision, memory concerns, medication side effects, medication interactions, social isolation, and the ability to manage everyday activities can have a major effect on health and independence.

Additional Minimum Checklist From Age 65

Women have completed osteoporosis screening, or were screened earlier because of elevated risk.

Men aged 65 to 75 with a history of smoking have completed a one-time abdominal aortic aneurysm ultrasound.

The value of continuing cancer screening has been reviewed based on previous results and overall health.

Falls risk, mobility, hearing, vision, memory, medications, and daily function have been reviewed.

Vaccinations are current for age and medical risk.

When the Standard Checklist Is Not Enough

An average-risk screening calendar may be inappropriate for people with a strong family history of early heart disease, stroke, diabetes, osteoporosis, or cancer; a known genetic variant or hereditary syndrome; previous abnormal screening results; inflammatory bowel disease; chronic kidney disease; diabetes; immune suppression; substantial smoking exposure; significant occupational exposure; pregnancy complications; or long-term use of medications that affect bones, blood pressure, glucose, or immune function.

A high-risk plan may begin earlier, use different tests, and involve shorter intervals.

Tests That Usually Do Not Belong in a Routine Preventive Minimum

For adults without symptoms and at average risk, there is no universal evidence-based requirement for annual broad testing.

The preventive minimum does not automatically include annual complete blood counts, annual comprehensive metabolic panels, repeated vitamin or hormone panels, broad tumor-marker panels, ovarian cancer screening with CA-125 or ultrasound, thyroid ultrasound, full-body CT or MRI, annual ECGs, routine cardiac stress tests, routine echocardiograms, or imaging performed “just in case.”

Some of these tests are appropriate when symptoms, medical conditions, medications, previous abnormalities, or family history provide a clear reason.

Low-value screening can lead to false-positive results, incidental findings, repeat testing, invasive procedures, unnecessary treatment, radiation exposure, cost, and prolonged uncertainty.

The USPSTF recommends against screening asymptomatic adults for thyroid cancer and against ovarian cancer screening in average-risk asymptomatic women. It also recommends against resting or exercise ECG screening for cardiovascular disease in asymptomatic adults at low cardiovascular risk. The FDA states that whole-body CT screening has not been shown to meet accepted criteria for an effective screening procedure in people without symptoms.

A Simple Personal Prevention Record

You do not need to memorize every screening interval. Keeping a basic personal record of family history, vaccinations, usual blood-pressure readings, lipid and glucose results, previous cancer screenings, smoking exposure, current medications, pregnancy complications, and major changes in weight, sleep, mood, or physical function is usually enough.

At a preventive appointment, ask which screenings are currently due, which are unnecessary for your risk level, when each test should be repeated, which symptoms should prompt earlier evaluation, and when a screening can safely stop.

The Bottom Line

A strong preventive plan is usually shorter than people expect.

For most adults at average risk, the evidence-based minimum consists of periodic blood-pressure and cardiovascular-risk assessment, current vaccinations, selected infection screening, mental-health and substance-use review, and a small number of age-specific cancer screenings.

The plan should expand when individual risk increases and remain limited when additional testing is unlikely to improve health.

The purpose of screening is to reduce the chance of serious disease and identify selected conditions early enough to change outcomes. It should not turn everyday life into a permanent search for abnormalities.

This article provides general educational information. Screening recommendations differ by country and individual risk. It does not replace personal medical advice, diagnosis, or treatment.

Last reviewed: June 2026.